Status:
COMPLETED
Neuroimaging Biomarkers of Prognosis in Motor Functional Neurological Disorders
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Conversion Disorder
Eligibility:
All Genders
18-65 years
Brief Summary
Functional Neurological Disorder (FND/ Conversion Disorder) is a highly prevalent and disabling neuropsychiatric condition. Motor FND symptoms include Nonepileptic Seizures, Functional Movement Disord...
Detailed Description
Functional Neurological Disorder (FND) (Conversion Disorder) is a poorly understood and prevalent somatoform disorder, making up 16% of outpatient neurology referrals. Patients with motor FND (mFND) a...
Eligibility Criteria
Inclusion
- clinically established motor functional neurological disorder, including individuals with functional movement disorders, functional limb weakness and psychogenic nonepileptic seizures
Exclusion
- active suicidality
- major medical/neurological comorbidities with known central nervous system (CNS) consequences
- active drug use or alcohol dependence
- known history of a primary psychotic disorder
Key Trial Info
Start Date :
September 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 20 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03398070
Start Date
September 1 2017
End Date
January 20 2023
Last Update
August 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114